Option chain shows key data for Alibaba Health Info Tech's stock options at various strike prices and expiration dates. Traders use this information to analyze potential trades and assess market sentiment for Alibaba Health Info Tech.

Alibaba Health Info Tech (OTC:ALBHF) Stock, Option Chain

Alibaba Health is of one of China's leading e-commerce platform specializing in healthcare-related products, including prescription drugs, OTC drugs, traditional Chinese medicine, health foods, and so on. The company operates both a third-party B2C service, or 3P, and its own direct-to-consumer business, or 1P, with its own inventory, which can both be accessed by Alibaba's Tmall app and Alipay. The company also provides online consultation services in a separate app called Yilu or "Dr. Deer," although its e-commerce businesses remain its core competency in the long-term. E-commerce accounted for 93% of revenue in fiscal year 2022. We estimate that AliHealth holds about 45% of market share in the industry in terms of GMV. AliHealth is 63.74% owned by its parent company, Alibaba Group.

Penny Stocks

ALBHF

MPNGY

Key Takeaways:


	Dingdang Health has passed a listing hearing in its second try at a Hong Kong IPO, aiming to raise $100 million
	The company has shifted from its original asset-light to a more asset-intensive model to make good on its promise of faster deliveries


By Emily Chan

Catching Listing Chill, Dingdang Health Slashes Hong Kong IPO

Fintech news covering the emerging Financial Technology services sector

Fintech

JDHIF

PANHF

Key takeaways:


	111’s revenue grew 87% in second quarter, generally outpacing its peers, as it aims to more than double its fulfillment capacity this year
	Company’s shares now trade around $6.50, well off a $23 high reached in February, as investors worry about regulatory wave for broader tech sector


By Mia Shanley

Solid Earnings, Modest Buyback Fail to Boost Drug Seller 111 Inc.

News

Health Care

Global

General

MRNA

CASBF

CanSino Biologics Inc. (OTC: CASBF), a Chinese vaccine maker, has emerged as the rising star of the Hong Kong market, after its COVID-19 clinical trial application was approved by Health Canada, the country&#39;s federal health policy department.

CanSino Biologics Shares Rose 380%  As COVID-19 Vaccine Promise Emerges

ALIBABA HEALTH INFO TECH by Alibaba Health Information Technology Ltd

Comments

Alibaba Health Info Tech

Alibaba Health Info Tech (ALBHF) Options

No option chain data available. Please try again later

Connect With Us

About Benzinga

Market Resources

Trading Tools & Education

Ring the Bell